Report Detail

The Asia Pacific cardiovascular devices market is expected to reach US$ 16,107.3 Mn in 2027 from US$ 8,852.6 Mn in 2018. The market is estimated to grow with a CAGR of 7.0% from 2019-2027.
The growth of the cardiovascular devices market is primarily attributed to the increasing acquisitions and collaboration activities and increasing rate of obesity. However, shortage of skilled workers is likely to pose a negative impact on the market growth. On the other hand, growth opportunities in the developing nations and declining prices of coronary stents are likely to have a positive impact on the growth of the Asia Pacific cardiovascular devices market in the coming years.
Obesity is one of the major problem and the biggest concern in all the countries across the region. Currently, more than one in two adults and nearly one in six children are obese. Obesity is one of the major issues that affects people of all ages and incomes globally. Overweight and obesity is the abnormal or excessive fat accumulation in the body leading to impaired health. There is a higher increasing risk of developing complications and premature mortality with obese population. Obesity plays a major role in increasing cardiovascular diseases among the population across the region. Lack of exercise and unhealthy diet such as diet high in fat and calories increase the risk for the development of cardiovascular disease (CVD). According the data of National Health and Nutrition Examination Survey, in 2015-2016, the obesity rate between the youth of the age group between 2 to 19 is 18.5%. The rate varies among different age groups, with rates rising along with age. While overall obesity rates remain higher than they were a generation ago. Lack of exercise, unhealthy diet, and rapid growth in the obese population is expected to increase the susceptibility of cardiovascular diseases among population in the region.
In 2018, the event monitor segment held a largest market share of 24.5% of the cardiovascular devices market, by device. The event monitor segment is expected to dominate its market share in 2027 owing to the advantages offered such as easy monitoring and recording the cardiac rhythms of the patients. The ECG segment is anticipated to witness the fastest growth rate of 8.3% during the forecast period, 2019 to 2027 owing to the technological advancements in the medical devices that allows the diagnose the heart beat in less time also the development has enabled to produce small and handy ECG devices.
In 2018, the coronary heart disease held a largest market share of 41.8% of the cardiovascular devices market, by application. The coronary heart disease segment is expected to dominate its market share in 2027 owing to the rising prevalence of the disease. However, the stroke segment is anticipated to witness the fastest growth rate of 7.9% during the forecast period, 2019 to 2027.
In 2018, the hospitals held a largest market share of 61.9% of the cardiovascular devices market, by end user. This segment is also expected to dominate the market in 2027 owing to the need for the cardiovascular surgery treatments that has become the major factor for the growth of the cardiovascular devices market. Also the hospitals segment is expected to grow at the fastest growth rate of 7.2% during the forecast period, 2019 to 2027.
Some of the major primary and secondary sources for cardiovascular devices included in the report are, Cardiovascular Disease Prevention and Rehabilitation (CVDPR), Health Technologies Fund (HTF), Innovative Medicines Initiatives (IMI), Center for Medicare & Medicaid Services (CMS), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), National Institute for Health and others.


TABLE OF CONTENTS

    1. Introduction

    • 1.1 Scope Of The Study
    • 1.2 The Insight Partners Research Report Guidance

    2. Asia Pacific Cardiovascular Devices Market - Key Takeaways

      3. Asia Pacific Cardiovascular Devices Market - Market Landscape

      • 3.1 Overview
      • 3.2 Market Segmentation
        • 3.2.1 Asia Pacific Cardiovascular Devices Market - By Device
        • 3.2.2 Asia Pacific Cardiovascular Devices Market - By Application
        • 3.2.3 Asia Pacific Cardiovascular Devices Market - By End User
        • 3.2.4 Asia Pacific Cardiovascular Devices Market - By Country
      • 3.3 Pest Analysis

      4. Asia Pacific Cardiovascular Devices Market - Key Market Dynamics

      • 4.1 Key Market Drivers
        • 4.1.1 Increasing Acquisitions and Collaboration Activities
        • 4.1.2 Increasing Rate of Obesity
      • 4.2 Key Market Restraints
        • 4.2.1 Shortage of Skilled Workers
      • 4.3 Key Market Opportunities
        • 4.3.1 Growth Opportunities in The Developing Nations
        • 4.3.2 Declining Prices of Coronary Stents
      • 4.4 Future Trends
        • 4.4.1 Increasing Prevalence of Obesity Across The Region
      • 4.5 Impact Analysis

      5. Cardiovascular Devices Market - Asia Pacific Analysis

      • 5.1 Asia Pacific Cardiovascular Devices Market Revenue Forecasts And Analysis
      • 5.2 Market Positioning
        • 5.2.1 Medtronic
        • 5.2.2 Abbott

      6. Asia Pacific Cardiovascular Devices Market Analysis - By Device

      • 6.1 Overview
      • 6.2 Asia Pacific Cardiovascular Devices Market By Device, 2018 & 2027 (%)
      • 6.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (Us$ Mn)
      • 6.4 Asia Pacific Cardiovascular Devices Volume Revenue And Forecasts To 2027, By Device (Units)
      • 6.5 Event Monitor Market
        • 6.5.1 Overview
        • 6.5.2 Event Monitor Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.6 Electrocardiography (Ecg) Market
        • 6.6.1 Overview
        • 6.6.2 Electrocardiography (ECG) Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.7 Cardiac Catheter Market
        • 6.7.1 Overview
        • 6.7.2 Cardiac Catheter Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.8 Stent Market
        • 6.8.1 Overview
        • 6.8.2 Stent Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.9 Defibrillator Market
        • 6.9.1 Overview
        • 6.9.2 Defibrillator Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.10 Guidewire Market
        • 6.10.1 Overview
        • 6.10.2 Guidewire Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.11 Pacemaker Market
        • 6.11.1 Overview
        • 6.11.2 Pacemaker Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.12 Heart Valve Market
        • 6.12.1 Overview
        • 6.12.2 Heart Valve Market Revenue and Forecast to 2027 (US$ Mn)
      • 6.13 Other Devices Market
        • 6.13.1 Overview
        • 6.13.2 Other Devices Market Revenue and Forecast to 2027 (US$ Mn)

      7. Asia Pacific Cardiovascular Devices Market Analysis - By Application

      • 7.1 Overview
      • 7.2 Asia Pacific Cardiovascular Devices Market, By Application, 2018 & 2027 (%)
      • 7.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Application (Us$ Mn)
      • 7.4 Coronary Heart Disease Market
        • 7.4.1 Overview
        • 7.4.2 Coronary Heart Disease Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.5 Stroke Market
        • 7.5.1 Overview
        • 7.5.2 Stroke Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.6 Sudden Cardiac Arrest Market
        • 7.6.1 Overview
        • 7.6.2 Sudden Cardiac Arrest Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.7 Cerebrovascular Heart Disease Market
        • 7.7.1 Overview
        • 7.7.2 Cerebrovascular Heart Disease Market Revenue and Forecast to 2027 (US$ Mn)
      • 7.8 Others Market
        • 7.8.1 Overview
        • 7.8.2 Others Market Revenue and Forecast to 2027 (US$ Mn)

      8. Asia Pacific Cardiovascular Devices Market Analysis - By End User

      • 8.1 Overview
      • 8.2 Asia Pacific Cardiovascular Devices Market, By End User, 2018 & 2027 (%)
      • 8.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn)
      • 8.4 Hospitals Market
        • 8.4.1 Overview
        • 8.4.2 Hospitals Market Revenue and Forecast to 2027 (US$ Mn)
      • 8.5 Cardiac Centers Market
        • 8.5.1 Overview
        • 8.5.2 Cardiac Centres Market Revenue and Forecast to 2027 (US$ Mn)
      • 8.6 Ambulatory Surgery Centers Market
        • 8.6.1 Overview
        • 8.6.2 Ambulatory Surgery Centers Market Revenue and Forecast to 2027 (US$ Mn)

      9. Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027

      • 9.1 Overview
      • 9.2 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027 (Us$ Mn)
      • 9.3 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Device (Us$ Mn)
      • 9.4 Asia Pacific Cardiovascular Devices Volume Revenue And Forecasts To 2027, By Device (Units)
        • 9.4.1 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)
      • 9.5 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By End User (Us$ Mn)
      • 9.6 Asia Pacific Cardiovascular Devices Market Revenue And Forecasts To 2027, By Country (%)
      • 9.7 China Cardiovascular Devices Market Revenue And Forecasts To 2027 (Us$ Mn)
        • 9.7.1 China Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
        • 9.7.2 China Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)
        • 9.7.3 China Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 9.7.4 China Cardiovascular Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 9.8 Japan Cardiovascular Devices Market Revenue And Forecasts To 2027 (Us$ Mn)
        • 9.8.1 Japan Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
        • 9.8.2 Japan Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)
        • 9.8.3 Japan Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 9.8.4 Japan Cardiovascular Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 9.9 India Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)
        • 9.9.1 India Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
        • 9.9.2 India Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)
        • 9.9.3 India Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 9.9.4 India Cardiovascular Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 9.10 Australia Cardiovascular Devices Market Revenue And Forecasts To 2027 (Us$ Mn)
        • 9.10.1 Australia Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
        • 9.10.2 Australia Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)
        • 9.10.3 Australia Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 9.10.4 Australia Cardiovascular Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)
      • 9.11 South Korea Cardiovascular Devices Market Revenue And Forecasts To 2027 (US$ Mn)
        • 9.11.1 South Korea Cardiovascular Devices Market Revenue and Forecasts to 2027 (US$ Mn)
        • 9.11.2 South Korea Cardiovascular Devices Market Revenue And Forecasts to 2027, By Device (US$ Mn)
        • 9.11.3 South Korea Cardiovascular Devices Market Revenue And Forecasts to 2027, By Application (US$ Mn)
        • 9.11.4 South Korea Cardiovascular Devices Market Revenue And Forecasts to 2027, By End User (US$ Mn)

      10. Cardiovascular Devices Market - Industry Landscape

      • 10.1 Overview
      • 10.2 Growth Strategies Done By The Companies In The Market, (%)
      • 10.3 Organic Growth Strategies
        • 10.3.1 Overview
        • 10.3.2 Product Launch & Up Gradation
        • 10.3.3 Approvals
        • 10.3.4 Others Developments
      • 10.4 Inorganic Growth Strategies
        • 10.4.1 Overview
        • 10.4.2 Acquisition
        • 10.4.3 Collaboration & Agreement

      11. Cardiovascular devices Market-Key Company Profiles

      • 11.1 Medtronic
        • 11.1.1 Key Facts
        • 11.1.2 Business Description
        • 11.1.3 Financial Overview
        • 11.1.4 Product Portfolio
        • 11.1.5 SWOT Analysis
        • 11.1.6 Key Developments
      • 11.2 Boston Scientific Corporation
        • 11.2.1 Key Facts
        • 11.2.2 Business Description
        • 11.2.3 Financial Overview
        • 11.2.4 Product Portfolio
        • 11.2.5 SWOT Analysis
        • 11.2.6 Key Developments
      • 11.3 Abbott
        • 11.3.1 Key Facts
        • 11.3.2 Business Description
        • 11.3.3 Financial Information
        • 11.3.4 Product Portfolio
        • 11.3.5 SWOT Analysis
        • 11.3.6 Key Developments
      • 11.4 Biosense Webster, Inc (Johnson And Johnson)
        • 11.4.1 Key Facts
        • 11.4.2 Business Description
        • 11.4.3 Financial Information
        • 11.4.4 Product Portfolio
        • 11.4.5 SWOT Analysis
        • 11.4.6 Key Developments
      • 11.5 General Electric Company
        • 11.5.1 Key Facts
        • 11.5.2 Business Description
        • 11.5.3 Financial Overview
        • 11.5.4 Product Portfolio
        • 11.5.5 SWOT Analysis
        • 11.5.6 Key Developments
      • 11.6 Koninklijke Philips N.V.
        • 11.6.1 Key Facts
        • 11.6.2 Business Description
        • 11.6.3 Financial Overview
        • 11.6.4 Product Portfolio
        • 11.6.5 SWOT ANALYSIS
        • 11.6.6 Key Developments
      • 11.7 Siemens Ag
        • 11.7.1 Key Facts
        • 11.7.2 Business Description
        • 11.7.3 Financial Overview
        • 11.7.4 Product Portfolio
        • 11.7.5 SWOT Analysis
        • 11.7.6 Key Developments
      • 11.8 BD
        • 11.8.1 Key Facts
        • 11.8.2 Business Description
        • 11.8.3 Financial Overview
        • 11.8.4 Product Portfolio
        • 11.8.5 SWOT Analysis
        • 11.8.6 Key Developments
      • 11.9 B. Braun Melsungen Ag
        • 11.9.1 Key Facts
        • 11.9.2 Business Description
        • 11.9.3 Financial Overview
        • 11.9.4 Product Portfolio
        • 11.9.5 SWOT Analysis
        • 11.9.6 Key Developments
      • 11.10 Edwards Lifesciences Corporation
        • 11.10.1 Key Facts
        • 11.10.2 Business Description
        • 11.10.3 Financial Overview
        • 11.10.4 Product Portfolio
        • 11.10.5 SWOT Analysis
        • 11.10.6 Key Developments

      12. Appendix

      • 12.1 About The Insight Partners
      • 12.2 Glossary Of Terms
      • 12.3 Methodology
        • 12.3.1 Coverage
        • 12.3.2 Secondary Research

      Summary:
      Get latest Market Research Reports on Asia Pacific Cardiovascular Devices. Industry analysis & Market Report on Asia Pacific Cardiovascular Devices is a syndicated market report, published as Asia Pacific Cardiovascular Devices Market to 2027 - Regional Analysis and Forecasts By Device (Electrocardiography (ECG), Pacemaker, Stent, Defibrillator, Cardiac Catheter, Guidewire, Heart Valve, Event Monitor, and Others); Application (Coronary Heart Disease, Sudden Cardiac Arrest, Stroke, Cerebrovascular Heart Disease and Others), End User (Hospitals, Ambulatory Surgery Centers, and Cardiac Centers), and Country. It is complete Research Study and Industry Analysis of Asia Pacific Cardiovascular Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,000.00
      $4,000.00
      $5,000.00
      2,400.00
      3,200.00
      4,000.00
      2,802.00
      3,736.00
      4,670.00
      471,990.00
      629,320.00
      786,650.00
      250,170.00
      333,560.00
      416,950.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report